Concepts (171)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Dependovirus | 13 | 2024 | 649 | 1.900 |
Why?
|
| Genetic Vectors | 10 | 2024 | 790 | 1.370 |
Why?
|
| Muscular Atrophy, Spinal | 1 | 2024 | 21 | 0.890 |
Why?
|
| MicroRNAs | 6 | 2024 | 617 | 0.880 |
Why?
|
| Gene Silencing | 3 | 2019 | 376 | 0.840 |
Why?
|
| Genetic Therapy | 10 | 2024 | 699 | 0.840 |
Why?
|
| Genome, Viral | 2 | 2019 | 120 | 0.700 |
Why?
|
| Inverted Repeat Sequences | 1 | 2017 | 14 | 0.570 |
Why?
|
| Osteoporosis | 3 | 2024 | 137 | 0.550 |
Why?
|
| DNA, Viral | 1 | 2017 | 228 | 0.530 |
Why?
|
| Mice | 17 | 2024 | 10210 | 0.460 |
Why?
|
| Myositis Ossificans | 2 | 2023 | 6 | 0.430 |
Why?
|
| Transgenes | 3 | 2024 | 170 | 0.420 |
Why?
|
| Gene Editing | 3 | 2024 | 280 | 0.390 |
Why?
|
| Animals | 21 | 2024 | 19519 | 0.380 |
Why?
|
| Disease Models, Animal | 5 | 2024 | 2046 | 0.360 |
Why?
|
| Nucleic Acid Conformation | 2 | 2019 | 231 | 0.290 |
Why?
|
| Schistosomiasis | 2 | 2018 | 4 | 0.280 |
Why?
|
| Activin Receptors, Type I | 2 | 2023 | 14 | 0.280 |
Why?
|
| Transduction, Genetic | 2 | 2019 | 224 | 0.270 |
Why?
|
| Macaca mulatta | 2 | 2024 | 246 | 0.270 |
Why?
|
| Capsid | 3 | 2023 | 88 | 0.250 |
Why?
|
| Gene Expression | 2 | 2019 | 805 | 0.240 |
Why?
|
| Alveolar Bone Loss | 1 | 2024 | 4 | 0.240 |
Why?
|
| Adenine | 1 | 2024 | 45 | 0.220 |
Why?
|
| CRISPR-Cas Systems | 2 | 2024 | 314 | 0.220 |
Why?
|
| Muscular Dystrophy, Duchenne | 1 | 2024 | 42 | 0.220 |
Why?
|
| Nanopores | 1 | 2022 | 9 | 0.210 |
Why?
|
| Ossification, Heterotopic | 1 | 2022 | 13 | 0.210 |
Why?
|
| RNA, Small Interfering | 2 | 2019 | 849 | 0.200 |
Why?
|
| Motor Neurons | 1 | 2024 | 206 | 0.200 |
Why?
|
| DNA-Binding Proteins | 2 | 2019 | 1126 | 0.200 |
Why?
|
| Bone and Bones | 2 | 2022 | 155 | 0.200 |
Why?
|
| Codon, Nonsense | 1 | 2022 | 51 | 0.200 |
Why?
|
| Mitochondrial Myopathies | 1 | 2021 | 3 | 0.200 |
Why?
|
| Thymidine Kinase | 1 | 2021 | 17 | 0.190 |
Why?
|
| Gene Transfer Techniques | 3 | 2021 | 304 | 0.190 |
Why?
|
| Humans | 18 | 2024 | 58964 | 0.190 |
Why?
|
| Antibodies, Neutralizing | 1 | 2023 | 192 | 0.190 |
Why?
|
| Fractures, Bone | 1 | 2022 | 137 | 0.190 |
Why?
|
| Gene Order | 2 | 2019 | 29 | 0.190 |
Why?
|
| Promoter Regions, Genetic | 1 | 2024 | 656 | 0.180 |
Why?
|
| Hepatic Stellate Cells | 2 | 2018 | 20 | 0.180 |
Why?
|
| Lung | 1 | 2024 | 819 | 0.170 |
Why?
|
| Capsid Proteins | 1 | 2020 | 94 | 0.160 |
Why?
|
| Dopaminergic Neurons | 1 | 2019 | 31 | 0.160 |
Why?
|
| Infant | 1 | 2024 | 1512 | 0.160 |
Why?
|
| RNA Stability | 1 | 2019 | 91 | 0.160 |
Why?
|
| Bone Resorption | 1 | 2019 | 49 | 0.160 |
Why?
|
| Monomeric GTP-Binding Proteins | 1 | 2019 | 39 | 0.160 |
Why?
|
| Corpus Striatum | 1 | 2019 | 96 | 0.160 |
Why?
|
| High-Throughput Screening Assays | 1 | 2019 | 73 | 0.160 |
Why?
|
| Cocaine | 1 | 2019 | 86 | 0.160 |
Why?
|
| RNA, Untranslated | 1 | 2019 | 101 | 0.160 |
Why?
|
| RNA, Viral | 1 | 2019 | 265 | 0.150 |
Why?
|
| Schistosoma | 1 | 2018 | 3 | 0.150 |
Why?
|
| Interleukin-33 | 1 | 2018 | 18 | 0.150 |
Why?
|
| Mitochondria | 1 | 2021 | 333 | 0.150 |
Why?
|
| Sex Characteristics | 1 | 2019 | 198 | 0.150 |
Why?
|
| Liver | 2 | 2019 | 773 | 0.140 |
Why?
|
| Sequence Deletion | 1 | 2017 | 114 | 0.140 |
Why?
|
| Genes, Reporter | 1 | 2017 | 243 | 0.130 |
Why?
|
| Plasmids | 1 | 2017 | 279 | 0.130 |
Why?
|
| Liver Diseases, Alcoholic | 1 | 2017 | 83 | 0.130 |
Why?
|
| Cell Line | 2 | 2019 | 2011 | 0.130 |
Why?
|
| RNA Interference | 1 | 2019 | 588 | 0.130 |
Why?
|
| Adenoviridae | 3 | 2022 | 119 | 0.130 |
Why?
|
| Sequence Analysis, DNA | 1 | 2017 | 394 | 0.130 |
Why?
|
| Liver Diseases, Parasitic | 1 | 2015 | 4 | 0.130 |
Why?
|
| Interleukin-13 | 1 | 2015 | 35 | 0.120 |
Why?
|
| DNA Replication | 1 | 2017 | 229 | 0.120 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2015 | 52 | 0.120 |
Why?
|
| Chromosomes, Human, Pair 8 | 2 | 2012 | 22 | 0.120 |
Why?
|
| Chromosomes, Human, Pair 21 | 2 | 2012 | 27 | 0.120 |
Why?
|
| Translocation, Genetic | 2 | 2012 | 64 | 0.120 |
Why?
|
| Receptors, AMPA | 1 | 2013 | 40 | 0.100 |
Why?
|
| Amygdala | 1 | 2013 | 78 | 0.100 |
Why?
|
| Reward | 1 | 2013 | 80 | 0.100 |
Why?
|
| Proto-Oncogene Proteins c-kit | 1 | 2012 | 32 | 0.100 |
Why?
|
| Boronic Acids | 1 | 2012 | 27 | 0.100 |
Why?
|
| Models, Biological | 1 | 2017 | 1137 | 0.100 |
Why?
|
| Pyrazines | 1 | 2012 | 32 | 0.100 |
Why?
|
| Osteogenesis | 2 | 2023 | 149 | 0.100 |
Why?
|
| Leukemia | 1 | 2012 | 53 | 0.100 |
Why?
|
| Mice, Inbred BALB C | 3 | 2019 | 880 | 0.100 |
Why?
|
| Learning | 1 | 2013 | 171 | 0.090 |
Why?
|
| Osteoblasts | 2 | 2024 | 204 | 0.090 |
Why?
|
| Adaptor Proteins, Signal Transducing | 2 | 2024 | 414 | 0.090 |
Why?
|
| Male | 7 | 2024 | 27346 | 0.090 |
Why?
|
| Transcription Factors | 1 | 2017 | 1453 | 0.080 |
Why?
|
| HEK293 Cells | 2 | 2020 | 566 | 0.070 |
Why?
|
| Mice, Transgenic | 2 | 2022 | 1219 | 0.070 |
Why?
|
| Diterpenes, Kaurane | 1 | 2006 | 2 | 0.070 |
Why?
|
| Diterpenes | 1 | 2006 | 19 | 0.070 |
Why?
|
| Core Binding Factor Alpha 2 Subunit | 1 | 2006 | 86 | 0.070 |
Why?
|
| Oncogene Proteins, Fusion | 1 | 2006 | 54 | 0.070 |
Why?
|
| Apoptosis | 2 | 2012 | 1034 | 0.060 |
Why?
|
| Substance-Related Disorders | 1 | 2013 | 688 | 0.060 |
Why?
|
| Down-Regulation | 2 | 2018 | 304 | 0.060 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 2006 | 163 | 0.060 |
Why?
|
| Utrophin | 1 | 2024 | 5 | 0.060 |
Why?
|
| Mice, Inbred mdx | 1 | 2024 | 18 | 0.060 |
Why?
|
| Cells, Cultured | 2 | 2019 | 2090 | 0.060 |
Why?
|
| Dystrophin | 1 | 2024 | 35 | 0.060 |
Why?
|
| Mutation | 2 | 2022 | 2420 | 0.060 |
Why?
|
| Wnt Signaling Pathway | 1 | 2024 | 71 | 0.060 |
Why?
|
| Myocytes, Cardiac | 1 | 2024 | 85 | 0.060 |
Why?
|
| Activins | 1 | 2023 | 54 | 0.050 |
Why?
|
| Tissue Distribution | 1 | 2024 | 280 | 0.050 |
Why?
|
| Terminal Repeat Sequences | 1 | 2022 | 13 | 0.050 |
Why?
|
| Codon, Terminator | 1 | 2022 | 21 | 0.050 |
Why?
|
| Oligonucleotides | 1 | 2024 | 205 | 0.050 |
Why?
|
| Nonsense Mediated mRNA Decay | 1 | 2022 | 21 | 0.050 |
Why?
|
| Mice, Inbred C57BL | 2 | 2019 | 3168 | 0.050 |
Why?
|
| Genetic Diseases, Inborn | 1 | 2022 | 36 | 0.050 |
Why?
|
| Compassionate Use Trials | 1 | 2021 | 2 | 0.050 |
Why?
|
| Thymidine | 1 | 2021 | 25 | 0.050 |
Why?
|
| RNA, Transfer | 1 | 2022 | 73 | 0.050 |
Why?
|
| Antineoplastic Agents | 1 | 2006 | 637 | 0.050 |
Why?
|
| DNA, Mitochondrial | 1 | 2021 | 75 | 0.050 |
Why?
|
| RNA | 1 | 2024 | 400 | 0.040 |
Why?
|
| Swine | 1 | 2021 | 337 | 0.040 |
Why?
|
| Blood-Brain Barrier | 1 | 2020 | 82 | 0.040 |
Why?
|
| Organ Culture Techniques | 1 | 2019 | 70 | 0.040 |
Why?
|
| Serogroup | 1 | 2019 | 30 | 0.040 |
Why?
|
| United States Food and Drug Administration | 1 | 2020 | 95 | 0.040 |
Why?
|
| DNA | 1 | 2024 | 784 | 0.040 |
Why?
|
| Cartilage | 1 | 2019 | 36 | 0.040 |
Why?
|
| Muscle, Skeletal | 1 | 2024 | 668 | 0.040 |
Why?
|
| Organ Specificity | 1 | 2019 | 178 | 0.040 |
Why?
|
| Locomotion | 1 | 2019 | 108 | 0.040 |
Why?
|
| Cryoelectron Microscopy | 1 | 2020 | 162 | 0.040 |
Why?
|
| Genetic Engineering | 1 | 2019 | 111 | 0.040 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2020 | 265 | 0.040 |
Why?
|
| Gene Deletion | 1 | 2019 | 298 | 0.040 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2019 | 248 | 0.040 |
Why?
|
| Computational Biology | 1 | 2019 | 323 | 0.040 |
Why?
|
| Amino Acid Sequence | 1 | 2020 | 1576 | 0.030 |
Why?
|
| Hepatocytes | 1 | 2017 | 187 | 0.030 |
Why?
|
| Models, Molecular | 1 | 2020 | 1113 | 0.030 |
Why?
|
| Smad7 Protein | 1 | 2015 | 1 | 0.030 |
Why?
|
| Immunity, Innate | 1 | 2021 | 764 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 2017 | 1048 | 0.030 |
Why?
|
| Adult | 2 | 2022 | 15640 | 0.030 |
Why?
|
| Extinction, Psychological | 1 | 2013 | 14 | 0.030 |
Why?
|
| Excitatory Postsynaptic Potentials | 1 | 2013 | 44 | 0.030 |
Why?
|
| Patch-Clamp Techniques | 1 | 2013 | 125 | 0.030 |
Why?
|
| Morphine | 1 | 2013 | 52 | 0.030 |
Why?
|
| Rats, Wistar | 1 | 2013 | 178 | 0.030 |
Why?
|
| Bortezomib | 1 | 2012 | 54 | 0.020 |
Why?
|
| Up-Regulation | 1 | 2013 | 362 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2013 | 591 | 0.020 |
Why?
|
| Brain | 1 | 2019 | 1477 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2013 | 846 | 0.020 |
Why?
|
| Female | 2 | 2024 | 30640 | 0.020 |
Why?
|
| Phosphorylation | 1 | 2012 | 858 | 0.020 |
Why?
|
| Rats | 1 | 2013 | 1904 | 0.020 |
Why?
|
| Analgesics, Opioid | 1 | 2013 | 488 | 0.020 |
Why?
|
| Protein Binding | 1 | 2012 | 1542 | 0.020 |
Why?
|
| U937 Cells | 1 | 2006 | 9 | 0.020 |
Why?
|
| RUNX1 Translocation Partner 1 Protein | 1 | 2006 | 11 | 0.020 |
Why?
|
| Cytarabine | 1 | 2006 | 34 | 0.020 |
Why?
|
| United States | 1 | 2020 | 7451 | 0.020 |
Why?
|
| Drug Screening Assays, Antitumor | 1 | 2006 | 83 | 0.020 |
Why?
|
| Plants, Medicinal | 1 | 2006 | 59 | 0.020 |
Why?
|
| Drug Synergism | 1 | 2006 | 132 | 0.020 |
Why?
|
| Neoplasms, Experimental | 1 | 2006 | 73 | 0.020 |
Why?
|
| Mice, Nude | 1 | 2006 | 257 | 0.020 |
Why?
|
| Plant Extracts | 1 | 2006 | 160 | 0.020 |
Why?
|
| Aged | 1 | 2017 | 13250 | 0.010 |
Why?
|
| Middle Aged | 1 | 2017 | 16172 | 0.010 |
Why?
|